(株)リボミックの貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4591/ - -
公表日公表担保貸付残高前週比借入残高（自己）前週比借入残高（転貸）前週比
2023/09/08日証協無担保167,000株0%260,900株0%1,468,375株0%
2023/09/08日証協有担保4,665,901株0%1,044,100株0%2,545,000株0%
2023/09/01日証協無担保167,000株0%258,900株0%1,468,475株0%
2023/09/01日証協有担保5,066,601株0%1,094,700株0%2,777,000株0%
2023/08/25日証協無担保167,000株0%270,300株0%1,465,075株0%
2023/08/25日証協有担保5,413,801株0%1,224,900株0%2,788,602株0%
2023/08/18日証協無担保167,000株0%275,800株0%1,484,375株0%
2023/08/18日証協有担保6,171,000株0%1,355,000株0%3,093,602株0%
2023/08/10日証協無担保167,000株0%274,500株0%1,462,775株0%
2023/08/10日証協有担保6,264,401株0%1,422,600株0%3,051,602株0%
2023/08/04日証協無担保167,000株0%273,300株0%1,441,174株0%
2023/08/04日証協有担保6,460,701株0%1,447,600株0%3,097,601株0%
2023/07/28日証協無担保166,800株0%279,100株0%1,395,974株0%
2023/07/28日証協有担保5,770,300株0%1,259,600株0%2,955,201株0%
2023/07/21日証協無担保166,600株0%274,700株0%1,397,564株0%
2023/07/21日証協有担保5,647,701株0%1,245,400株0%2,907,001株0%
2023/07/14日証協無担保166,600株0%276,700株0%1,405,164株0%
2023/07/14日証協有担保5,926,100株0%1,280,100株0%3,022,501株0%
2023/07/07日証協無担保166,600株0%273,700株0%1,407,964株0%
2023/07/07日証協有担保5,675,900株0%1,214,400株0%2,901,401株0%
2023/06/30日証協無担保166,600株0%270,900株0%1,361,864株0%
2023/06/30日証協有担保5,728,500株0%1,269,200株0%2,885,701株0%
2023/06/23日証協無担保166,600株0%259,200株0%1,361,878株0%
2023/06/23日証協有担保4,945,801株0%1,166,300株0%2,538,400株0%
2023/06/16日証協無担保166,600株0%259,100株0%1,352,078株0%
2023/06/16日証協有担保5,297,201株0%1,218,500株0%2,608,100株0%
2023/06/09日証協無担保166,600株0%262,200株0%1,424,778株0%
2023/06/09日証協有担保5,721,501株0%1,263,700株0%2,821,200株0%
2023/06/02日証協無担保166,600株0%261,400株0%1,370,377株0%
2023/06/02日証協有担保5,998,701株0%1,319,400株0%2,914,900株0%
2023/05/26日証協無担保166,600株0%237,700株0%1,315,677株0%
2023/05/26日証協有担保5,386,601株0%1,321,100株0%2,603,300株0%
2023/05/19日証協無担保166,600株0%226,600株0%1,309,277株0%
2023/05/19日証協有担保5,993,901株0%1,456,100株0%2,872,200株0%
2023/05/12日証協無担保166,600株0%232,000株0%1,307,577株0%
2023/05/12日証協有担保6,847,401株0%1,499,400株0%3,320,701株0%
2023/05/02日証協無担保166,600株0%237,900株-0.38%1,339,077株+2.07%
2023/05/02日証協有担保7,982,300株-0.82%1,531,900株-0.24%3,914,801株-0.6%

※株式分割は考慮していませんのでご注意ください。

Page Top